Home> Products> independence

{ "products": [ { "_id": "68beb3498d01aa56733d32d9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Rivastigmine capsules IP 3 mg", "description": "PYRITIGMIN RIVA 3\nRivastigmine Capsules IP 3 mg\nPyritigmin Riva 3 is a trusted and effective formulation containing Rivastigmine Capsules IP 3 mg, designed to support patients suffering from cognitive decline associated with Alzheimer’s disease and Parkinson’s disease dementia. Manufactured with precision and care by Steris Healthcare, this medication belongs to the class of cholinesterase inhibitors and works by improving communication between nerve cells in the brain.\nAlzheimer’s disease and Parkinson’s disease dementia are progressive neurological conditions that impair memory, thinking, and overall cognitive function. While there is currently no cure, Pyritigmin Riva 3 offers symptomatic relief by enhancing mental clarity, reducing memory loss, and helping patients maintain daily functional independence for longer.\nComposition\nActive Ingredient: Rivastigmine Capsules IP 3 mg\nBrand Name: Pyritigmin Riva 3\nFormulation: Hard gelatin capsules\nUses of Rivastigmine Capsules (Pyritigmin Riva 3)\nAlzheimer’s Disease: Helps reduce memory loss, confusion, and cognitive decline.\nParkinson’s Disease Dementia: Improves focus, alertness, and reduces confusion.\nMild to Moderate Dementia: Enhances daily living activities and maintains patient independence.\nCognitive Function Support: Improves learning ability and attention span.\nHow Does Pyritigmin Riva 3 Work?\nRivastigmine, the main component of Pyritigmin Riva 3, works as a cholinesterase inhibitor. It blocks the enzymes acetylcholinesterase and butyrylcholinesterase, which break down acetylcholine—a neurotransmitter essential for memory and learning. By preventing its breakdown, Rivastigmine increases acetylcholine levels in the brain, thereby improving nerve cell communication.\nThis mechanism slows the worsening of symptoms, giving patients more time to maintain their mental functions and quality of life.\nDosage and Administration\nTypical Dose: One capsule of Pyritigmin Riva 3 (Rivastigmine 3 mg) twice daily with food, or as directed by your doctor.\nTitration: The dose may be adjusted gradually depending on tolerance and effectiveness.\nAdministration:\nSwallow the capsule whole with a glass of water.\nDo not crush or chew.\nTake at the same time each day to maintain stable drug levels.\nKey Benefits of Pyritigmin Riva 3\nImproves Memory Retention – Enhances recall ability and reduces forgetfulness.\nSlows Symptom Progression – Delays worsening of dementia symptoms.\nSupports Daily Activities – Helps patients maintain independence in dressing, eating, and communication.\nDual Action in Dementia – Effective in both Alzheimer’s disease and Parkinson’s-related dementia.\nWell-Tolerated Formulation – Designed for safe, effective long-term use.\nPossible Side Effects\nLike all medications, Pyritigmin Riva 3 may cause side effects in some individuals.\nCommon Side Effects:\nNausea\nVomiting\nLoss of appetite\nDizziness\nStomach pain\nDiarrhea\nSerious Side Effects (rare):\nSevere weight loss\nFainting or irregular heartbeat\nSeizures\nSevere allergic reaction (rash, swelling, breathing difficulty)\nPrecautions and Warnings\nInform your doctor if you have a history of heart problems, asthma, peptic ulcers, or seizures.\nUse with caution in patients with low body weight.\nAvoid alcohol, as it may worsen side effects.\nNot recommended during pregnancy or breastfeeding unless prescribed by a doctor.\nShould be used only under strict medical supervision.\nDrug Interactions\nRivastigmine may interact with:\nOther cholinergic drugs (donepezil, galantamine) – risk of side effects increases.\nAnticholinergic drugs – reduced effectiveness.\nBeta-blockers – may increase risk of slow heart rate.\nNSAIDs (like ibuprofen, aspirin) – may increase stomach irritation risk.\nAlways inform your healthcare provider about all medications you are taking.\nWhy Choose Steris Healthcare for Pyritigmin Riva 3?\nSteris Healthcare is a leading pharmaceutical company recognized for its commitment to quality, safety, and affordability. By choosing Pyritigmin Riva 3, patients and caregivers can trust:\nWHO-GMP Certified Manufacturing – Assuring international quality standards.\nStringent Quality Control – Every batch is tested for safety and efficacy.\nAffordable Pricing – Making dementia care accessible for all patients.\nPan-India Distribution – Easy availability across pharmacies and hospitals.\nPatient-Centric Approach – Focused on improving patient outcomes and quality of life.\nSteris Healthcare ensures that Pyritigmin Riva 3 (Rivastigmine Capsules IP 3 mg) is a reliable, safe, and effective solution for managing dementia-related symptoms.", "price": 250.0, "discountamount": 175.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2177, "imageuri": "https://productimages.withfloats.com/actual/68beb3505b1b9933009f8517.png", "tileimageuri": "https://productimages.withfloats.com/tile/68beb3505b1b9933009f8517.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-08T10:43:21.61Z", "updatedon": "2025-09-08T10:43:21.61Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/rivastigmine-capsules-ip-3-mg/2177", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PYRITIGMIN RIVA 3", "category": "NEUROLOGY RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666be6b8aa93342004eef58f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROPINPRIME 2 ", "description": "ROPINPRIME 2 \nRopinirole (2mg)\nIntroduction:\n\nRopinprime 2 is a medication containing Ropinirole, a potent dopamine agonist used primarily for treating Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 2mg, Ropinprime 2 is designed to effectively alleviate symptoms by mimicking dopamine's action in the brain, thus improving motor function and enhancing the quality of life for patients.\nKey Features and Benefits:\n\nDopamine Agonist:\n\nRopinprime 2 acts as a dopamine agonist, stimulating dopamine receptors in the brain. This action helps reduce motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 2 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 2 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 2mg dosage strength allows for flexible dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage for Parkinson's Disease:\n\nThe recommended starting dose of Ropinprime 2 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability. Maintenance doses usually range from 1mg to 8mg per day, divided into multiple doses.\nInitial Dosage for Restless Legs Syndrome:\n\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. The dose may be increased to 0.5mg and then to 1mg, depending on patient response and symptom control.\nAdministration Instructions:\n\nSwallow Ropinprime 2 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\n\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 2 therapy to ensure therapeutic efficacy and patient safety.\n\n\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/ropinprime-2-133629", "price": 135.0, "discountamount": 40.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "RLS", "1mg", "8mg", "life", "aids", "food", "brain", "Order", "EMAIL", "0.5mg", "water", "0.25mg", "action", "nausea", "bedtime", "disease", "tremors", "patients", "Benefits", "condition", "Parkinson", "stiffness", "Ropinirole", "likelihood", "medication", "information", "Introduction", "bradykinesia", "independence", "tolerability", "initial dose", "sterisonline", "sterispharma", "greater ease", "Key Features", "CALL/WHATSAPP", "sleep quality", "starting dose", "motor symptoms", "patient safety", "multiple doses", "Initial Dosage", "overall comfort", "treatment plans", "slowed movement", "symptom control", "patient response", "symptom severity", "daily activities", "clinical response", "Maintenance doses", "Regular monitoring", "dopamine receptors", "uncontrollable urge", "2mg dosage strength", "Ropinprime 2 therapy", "healthcare providers", "therapeutic efficacy", "Continued Monitoring", "dopaminergic activity", "overall motor function", "potential side effects", "potent dopamine agonist", "Improved Motor Function", "uncomfortable sensations", "flexible dosing regimens", "individual patient needs", "Administration Instructions", "Swallow Ropinprime 2 tablets", "Restless Legs Syndrome Relief" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1895, "imageuri": "https://productimages.withfloats.com/actual/667d15dbce74849f89cdd68a.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d15dbce74849f89cdd68a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:44:08.261Z", "updatedon": "2024-06-27T07:33:46.566Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-2-/1895", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROPINPRIME 2 ", "category": "NEUROLOGY RANGE", "tags": [ "Ropinirole (2mg)", "ROPINPRIME 2", "ropinirole side effects", "ropinirole side effects: weight gain", "ropinirole side effects in elderly" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666be5a070774b1f84f699ad", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROPINPRIME 1 ", "description": "ROPINPRIME 1 \nRopinirole (1mg)\nIntroduction:\n\nRopinprime 1 contains Ropinirole, a potent dopamine agonist used primarily to treat Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 1mg, Ropinprime 1 is designed to alleviate symptoms by mimicking the action of dopamine in the brain, thereby improving motor function and enhancing the quality of life for patients.\nKey Features and Benefits:\n\nDopamine Agonist:\n\nRopinprime 1 acts as a dopamine agonist, stimulating dopamine receptors in the brain. This mechanism helps reduce the motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 1 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 1 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 1mg dosage strength provides flexibility in dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage for Parkinson's Disease:\n\nThe recommended starting dose of Ropinprime 1 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability. Maintenance doses usually range from 1mg to 8mg per day, divided into multiple doses.\nInitial Dosage for Restless Legs Syndrome:\n\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. The dose may be increased to 0.5mg and then to 1mg, depending on patient response and symptom control.\nAdministration Instructions:\n\nSwallow Ropinprime 1 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\n\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 1 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/ropinprime-1-133628", "price": 124.0, "discountamount": 37.2, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "RLS", "day", "8mg", "life", "food", "EMAIL", "water", "0.5mg", "Order", "brain", "nausea", "action", "0.25mg", "bedtime", "disease", "tremors", "patients", "Benefits", "movement", "mechanism", "condition", "Parkinson", "stiffness", "medication", "likelihood", "Ropinirole", "flexibility", "information", "bradykinesia", "independence", "tolerability", "Introduction", "sterisonline", "initial dose", "sterispharma", "Key Features", "greater ease", "CALL/WHATSAPP", "starting dose", "sleep quality", "motor symptoms", "Initial Dosage", "multiple doses", "patient safety", "symptom control", "treatment plans", "dosing regimens", "Flexible Dosing", "overall comfort", "symptom severity", "patient response", "daily activities", "Maintenance doses", "clinical response", "dopamine receptors", "Regular monitoring", "1mg dosage strength", "uncontrollable urge", "Continued Monitoring", "therapeutic efficacy", "healthcare providers", "Ropinprime 1 therapy", "dopaminergic activity", "overall motor function", "potential side effects", "potent dopamine agonist", "Improved Motor Function", "individual patient needs", "uncomfortable sensations", "Administration Instructions", "Swallow Ropinprime 1 tablets", "Restless Legs Syndrome Relief" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1894, "imageuri": "https://productimages.withfloats.com/actual/666be5a4475de163fe91643d.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666be5a4475de163fe91643d.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:39:28.983Z", "updatedon": "2024-06-26T07:04:00.123Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-1-/1894", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROPINPRIME 1 ", "category": "NEUROLOGY RANGE", "tags": [ "ROPINPRIME 1", "ropinirole side effects in elderly", "ropinirole side effects", "ropinirole warnings" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666be4714cb45413344ec323", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROPINPRIME 0.5 ", "description": "ROPINPRIME 0.5 \nRopinirole (0.5mg)\nIntroduction:\n\nRopinprime 0.5 contains Ropinirole, a dopamine agonist used primarily for treating Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 0.5mg, Ropinprime 0.5 aims to alleviate symptoms by mimicking the action of dopamine in the brain, thus improving motor function and enhancing quality of life for patients.\nKey Features and Benefits:\n\nDopamine Agonist:\n\nRopinprime 0.5 acts as a dopamine agonist, directly stimulating dopamine receptors in the brain. This action helps reduce the motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 0.5 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 0.5 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 0.5mg dosage strength allows for flexible dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage:\nThe recommended starting dose of Ropinprime 0.5 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability.\nRestless Legs Syndrome:\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. Dosage may be adjusted according to patient response and symptom control.\nAdministration Instructions:\nSwallow Ropinprime 0.5 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 0.5 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/ropinprime-0-5-133627", "price": 60.0, "discountamount": 18.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "RLS", "aids", "life", "food", "Order", "water", "brain", "EMAIL", "0.25mg", "nausea", "action", "bedtime", "disease", "tremors", "patients", "Benefits", "stiffness", "condition", "Parkinson", "Ropinirole", "likelihood", "medication", "information", "Introduction", "initial dose", "independence", "greater ease", "tolerability", "Key Features", "sterispharma", "bradykinesia", "sterisonline", "CALL/WHATSAPP", "sleep quality", "starting dose", "patient safety", "motor symptoms", "Initial Dosage", "overall comfort", "treatment plans", "slowed movement", "symptom control", "dopamine agonist", "patient response", "daily activities", "symptom severity", "clinical response", "Regular monitoring", "dopamine receptors", "uncontrollable urge", "Continued Monitoring", "healthcare providers", "therapeutic efficacy", "0.5mg dosage strength", "dopaminergic activity", "Ropinprime 0.5 therapy", "overall motor function", "potential side effects", "Improved Motor Function", "individual patient needs", "uncomfortable sensations", "flexible dosing regimens", "Administration Instructions", "Restless Legs Syndrome Relief", "Swallow Ropinprime 0.5 tablets" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1893, "imageuri": "https://productimages.withfloats.com/actual/666be475844f2600246a0b63.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666be475844f2600246a0b63.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:34:25.708Z", "updatedon": "2024-06-26T07:04:57.853Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-0-5-/1893", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROPINPRIME 0.5 ", "category": "NEUROLOGY RANGE", "tags": [ "ropinprime 0.5 mg tablet 10", "ropinprime 0.5 mg tablet uses", "ropin 0.5 injection", "ropinirole warnings", "ropinirole side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ae69aaebebd0900165264", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "RASAGAIL 1", "description": "RASAGAIL 1\nRasagail 1.0 \nIntroduction:\n\nRasagail 1.0 embodies the therapeutic efficacy of Rasagiline, a potent monoamine oxidase-B (MAO-B) inhibitor renowned for its role in managing Parkinson's disease. With a dosage strength of 1.0mg, Rasagail 1.0 offers a targeted approach to alleviate symptoms, enhance motor function, and potentially slow disease progression in Parkinson's patients.\nKey Features and Benefits:\n\nMAO-B Inhibition:\n\nRasagail 1.0 exerts its primary action by selectively inhibiting MAO-B enzymes, leading to increased dopamine levels within the brain's striatum. This mechanism aids in alleviating motor symptoms and improving overall motor function.\nNeuroprotection:\n\nBeyond symptom relief, Rasagail 1.0 demonstrates neuroprotective properties by reducing oxidative stress, preserving neuronal integrity, and potentially exerting disease-modifying effects in Parkinson's disease.\nImproved Motor Function:\n\nBy enhancing dopaminergic neurotransmission, Rasagail 1.0 contributes to smoother motor coordination, reduced rigidity, tremors, and bradykinesia, fostering greater mobility and functional independence.\nFlexible Dosing:\n\nRasagail 1.0 allows for flexible dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, disease severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage:\nThe recommended starting dose of Rasagail 1.0 is 1.0mg once daily, administered orally with or without food. Dosage adjustments may be considered based on individual patient response and tolerability.\nTitration and Maintenance:\nTitration of Rasagail 1.0 may occur under medical supervision to achieve optimal therapeutic benefits while minimizing adverse effects. Maintenance doses are typically adjusted as needed to sustain symptom control.\nContinued Monitoring:\nOngoing clinical monitoring of Parkinson's disease symptoms, motor function, and potential side effects is essential during Rasagail 1.0 therapy to ensure treatment efficacy and patient safety.For further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/rasagail-1-0-133623\n", "price": 135.0, "discountamount": 40.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "role", "food", "brain", "1.0mg", "Order", "EMAIL", "tremors", "patients", "rigidity", "striatum", "Titration", "Parkinson", "mechanism", "Rasagiline", "information", "Introduction", "Key Features", "sterisonline", "sterispharma", "tolerability", "bradykinesia", "starting dose", "CALL/WHATSAPP", "MAO-B enzymes", "Initial Dosage", "Administration", "patient safety", "symptom relief", "motor symptoms", "primary action", "treatment plans", "adverse effects", "symptom control", "dosage strength", "Neuroprotection", "dopamine levels", "MAO-B Inhibition", "disease symptoms", "disease severity", "greater mobility", "oxidative stress", "MAO-B) inhibitor", "Maintenance doses", "targeted approach", "treatment efficacy", "neuronal integrity", "Dosage adjustments", "medical supervision", "disease progression", "healthcare providers", "Continued Monitoring", "therapeutic efficacy", "Rasagail 1.0 therapy", "potential side effects", "overall motor function", "functional independence", "Improved Motor Function", "individual patient needs", "flexible dosing regimens", "disease-modifying effects", "potent monoamine oxidase-B", "neuroprotective properties", "Ongoing clinical monitoring", "smoother motor coordination", "individual patient response", "optimal therapeutic benefits", "dopaminergic neurotransmission" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1888, "imageuri": "https://productimages.withfloats.com/actual/666ae69dc9162f54a1593ccc.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666ae69dc9162f54a1593ccc.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:31:22.172Z", "updatedon": "2024-06-26T07:19:57.74Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/rasagail-1/1888", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RASAGAIL 1", "category": "NEUROLOGY RANGE", "tags": [ "RASAGAIL 1", "rasagiline 1 mg price", "rasagiline 1 mg uses", "rasagiline benefits", "rasagiline side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ae5c5ca84cd189c25cbff", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Rasagail 0.5 ", "description": "Rasagail 0.5 \nRasagiline (0.5mg)\nIntroduction:\n\nRasagail 0.5 encapsulates the medicinal prowess of Rasagiline, a potent and selective monoamine oxidase-B (MAO-B) inhibitor used in the management of Parkinson's disease. With a dosage strength of 0.5mg, Rasagail 0.5 aims to optimize neurological function and enhance quality of life for individuals battling Parkinson's disease.\nKey Features and Benefits:\n\nMAO-B Inhibition:\n\nRasagail 0.5 exerts its therapeutic effects by selectively inhibiting MAO-B enzymes, thereby increasing dopamine levels in the brain's striatum. This mechanism helps alleviate motor symptoms and improve motor function in Parkinson's disease.\nNeuroprotective Properties:\n\nBeyond symptomatic relief, Rasagail 0.5 offers neuroprotective benefits by reducing oxidative stress, preventing neuronal damage, and potentially slowing disease progression in Parkinson's patients.\nEnhanced Dopaminergic Transmission:\n\nBy enhancing dopaminergic neurotransmission, Rasagail 0.5 contributes to smoother motor coordination, reduced rigidity, tremors, and bradykinesia, fostering greater mobility and independence.\nAdjunctive Therapy:\n\nRasagail 0.5 can be used as monotherapy in early-stage Parkinson's disease or as an adjunct to levodopa/carbidopa in advanced stages, providing a comprehensive approach to symptom management.\nDosage and Administration:\n\nInitial Dosage:\nThe recommended starting dose of Rasagail 0.5 is 0.5mg once daily, taken orally with or without food. Dosage adjustments may be made based on individual patient response and tolerability.\nTitration and Maintenance:\nGradual titration may occur as directed by healthcare providers to achieve optimal therapeutic benefits while minimizing side effects. Maintenance doses are typically tailored to individual patient needs.\nContinued Monitoring:\nRegular clinical assessments and monitoring of Parkinson's disease symptoms, motor function, and potential adverse effects are essential components of Rasagail 0.5 therapy to ensure treatment efficacy and safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/rasagail-0-5-133622", "price": 75.0, "discountamount": 22.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "life", "EMAIL", "Order", "0.5mg", "brain", "safety", "tremors", "quality", "striatum", "rigidity", "patients", "carbidopa", "mechanism", "Rasagiline", "monotherapy", "information", "individuals", "Introduction", "sterisonline", "Key Features", "bradykinesia", "independence", "side effects", "tolerability", "sterispharma", "CALL/WHATSAPP", "MAO-B enzymes", "starting dose", "Administration", "Initial Dosage", "motor function", "motor symptoms", "dopamine levels", "dosage strength", "neuronal damage", "advanced stages", "MAO-B) inhibitor", "oxidative stress", "greater mobility", "MAO-B Inhibition", "disease symptoms", "Maintenance doses", "medicinal prowess", "Gradual titration", "Adjunctive Therapy", "symptom management", "Dosage adjustments", "treatment efficacy", "symptomatic relief", "therapeutic effects", "disease progression", "essential components", "healthcare providers", "Rasagail 0.5 therapy", "Continued Monitoring", "neurological function", "early-stage Parkinson", "comprehensive approach", "neuroprotective benefits", "individual patient needs", "potential adverse effects", "Neuroprotective Properties", "individual patient response", "smoother motor coordination", "optimal therapeutic benefits", "Regular clinical assessments", "selective monoamine oxidase-B", "dopaminergic neurotransmission", "Enhanced Dopaminergic Transmission" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1887, "imageuri": "https://productimages.withfloats.com/actual/666ae5c88c6c791fd3b65cab.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666ae5c88c6c791fd3b65cab.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:27:49.832Z", "updatedon": "2024-06-26T07:22:12.294Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//rasagail-0-5-/1887", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Rasagail 0.5 ", "category": "NEUROLOGY RANGE", "tags": [ "rasagiline side effects", "rasagiline benefits", "long-term side effects of rasagiline", "rasagiline uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66698007162db023604894db", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DONEPAZE M ", "description": "DONEPAZE M \nDonepazil 5mg + Mentatime 5mg\nIntroduction\nDONEPAZE M combines Donepezil (5 mg) and Memantine (5 mg) to offer a comprehensive treatment for Alzheimer's disease and cognitive enhancement. This combination medication works by targeting multiple pathways involved in the cognitive decline associated with Alzheimer's, providing a more robust solution for managing the symptoms of the disease and improving overall brain function.\n\nKey Ingredients and Their Benefits\nDonepezil (5 mg)\nCognitive Enhancement: Donepezil is a cholinesterase inhibitor that increases the levels of acetylcholine, a neurotransmitter essential for memory and learning, in the brain.\nMemory Improvement: By slowing the breakdown of acetylcholine, Donepezil helps enhance memory and learning capabilities in patients with Alzheimer's disease.\nSymptom Management: It effectively manages the symptoms of mild to moderate Alzheimer's disease, helping patients maintain their daily functions and quality of life.\nSlow Progression: Donepezil can slow the progression of Alzheimer's symptoms, providing significant benefits to patients and caregivers.\nMemantine (5 mg)\nNMDA Receptor Antagonist: Memantine works by blocking NMDA receptors, which are involved in the overactivation that can lead to neuronal damage in Alzheimer's disease.\nNeuroprotection: By regulating the activity of glutamate, Memantine helps protect neurons from excitotoxicity and supports brain health.\nCognitive Improvement: Memantine helps improve cognitive function, including memory, attention, and problem-solving skills in patients with moderate to severe Alzheimer's disease.\nBehavioral Symptom Management: It can also help manage behavioral symptoms associated with Alzheimer's, such as agitation and aggression.\nBenefits of DONEPAZE M\nDual Mechanism of Action: DONEPAZE M combines the benefits of Donepezil and Memantine, targeting multiple pathways involved in Alzheimer's disease for more comprehensive symptom management.\nEnhanced Cognitive Function: The combination improves cognitive abilities, including memory, attention, and problem-solving skills, in patients with Alzheimer's disease.\nSymptom Relief: It effectively manages both cognitive and behavioral symptoms of Alzheimer's, helping patients maintain their independence and perform daily activities.\nNeuroprotection: DONEPAZE M provides neuroprotective benefits by regulating neurotransmitter activity and protecting neurons from damage.\nOnce-Daily Dosing: The convenience of once-daily dosing improves patient compliance and ensures consistent therapeutic effects.\nDosage and Administration\nDosage\nAlzheimer’s Disease: The recommended starting dose is one tablet (Donepezil 5 mg + Memantine 5 mg) taken once daily. The dosage may be adjusted by the healthcare provider based on the patient's response and tolerance.\nAdministration\nOral Use: Swallow the tablet whole with a full glass of water. It can be taken with or without food.\nConsistency: For optimal results, take DONEPAZE M at the same time each day to maintain consistent medication levels in your bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/donepaze-m-133559", "price": 167.0, "discountamount": 50.1, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mild", "life", "food", "EMAIL", "Order", "water", "Action", "Dosing", "quality", "disease", "neurons", "Oral Use", "response", "patients", "attention", "agitation", "same time", "tolerance", "glutamate", "Donepazil", "Mentatime", "Memantine", "breakdown", "aggression", "one tablet", "full glass", "caregivers", "DONEPAZE M", "bloodstream", "Consistency", "moderate to", "convenience", "information", "Introduction", "sterispharma", "sterisonline", "independence", "brain health", "acetylcholine", "starting dose", "CALL/WHATSAPP", "NMDA receptors", "excitotoxicity", "Dual Mechanism", "Symptom Relief", "Donepezil 5 mg", "overactivation", "Donepezil (5 mg", "Neuroprotection", "robust solution", "Key Ingredients", "daily functions", "optimal results", "neuronal damage", "severe Alzheimer", "Slow Progression", "daily activities", "cognitive decline", "multiple pathways", "moderate Alzheimer", "Memory Improvement", "patient compliance", "cognitive abilities", "behavioral symptoms", "healthcare provider", "significant benefits", "cognitive enhancement", "learning capabilities", "Administration Dosage", "Cognitive Improvement", "combination medication", "overall brain function", "problem-solving skills", "comprehensive treatment", "NMDA Receptor Antagonist", "neuroprotective benefits", "cholinesterase inhibitor", "neurotransmitter activity", "Enhanced Cognitive Function", "consistent medication levels", "Behavioral Symptom Management", "consistent therapeutic effects", "comprehensive symptom management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1823, "imageuri": "https://productimages.withfloats.com/actual/666980260b4fc76a99a080d2.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666980260b4fc76a99a080d2.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T11:01:27.347Z", "updatedon": "2024-06-27T05:51:11.327Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/donepaze-m-/1823", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DONEPAZE M ", "category": "NEUROLOGY RANGE", "tags": [ "Mentatime 5mg", "Donepazil 5mg", "donepaze m tablet uses in hindi", "donepaze m tablet uses in telugu", "DONEPAZE M tablets price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66697de9c4201222ec34888d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DONEPAZE 5 ", "description": "DONEPAZE 5 \nDonepazil (5mg)\nIntroduction\nDONEPAZE 5 contains Donepezil (5 mg), a cholinesterase inhibitor used to treat the symptoms of Alzheimer’s disease. Donepezil works by increasing the levels of acetylcholine, a neurotransmitter associated with memory and learning, in the brain. This medication is designed to improve cognitive function, enhance memory, and slow the progression of symptoms in patients with Alzheimer's disease.\n\nKey Ingredient and Its Benefits\nDonepezil (5 mg)\nCognitive Enhancement: Donepezil improves cognitive function in patients with Alzheimer’s disease by increasing the availability of acetylcholine in the brain.\nMemory Improvement: It helps enhance memory and learning capabilities by slowing the breakdown of acetylcholine, a neurotransmitter essential for these processes.\nSymptom Management: Donepezil is effective in managing the symptoms of mild to moderate Alzheimer’s disease, helping patients maintain their daily functions and quality of life.\nSlow Progression: While not a cure, Donepezil can slow the progression of Alzheimer's symptoms, providing significant benefits to patients and caregivers.\nBenefits of DONEPAZE 5\nImproved Cognitive Function: DONEPAZE 5 enhances cognitive abilities, including memory, attention, and problem-solving skills, in patients with Alzheimer’s disease.\nSymptom Relief: It effectively manages the symptoms of Alzheimer’s disease, helping patients maintain their independence and perform daily activities.\nEnhanced Quality of Life: By improving cognitive function and slowing symptom progression, DONEPAZE 5 enhances the overall quality of life for patients and provides relief for caregivers.\nOnce-Daily Dosing: The convenience of once-daily dosing improves patient compliance and ensures consistent therapeutic effects.\nDosage and Administration\nDosage\nAlzheimer’s Disease: The recommended starting dose is 5 mg once daily, which may be increased to 10 mg once daily after 4-6 weeks based on clinical response and tolerance. The exact dosage should be determined by a healthcare provider.\nAdministration\nOral Use: Swallow the tablet whole with a full glass of water. It can be taken with or without food.\nConsistency: For optimal results, take DONEPAZE 5 at the same time each day to maintain consistent medication levels in your bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/donepaze-5-133558", "price": 114.0, "discountamount": 34.2, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "life", "food", "5 mg", "cure", "mild", "Order", "EMAIL", "water", "10 mg", "brain", "tablet", "Dosing", "disease", "product", "Oral Use", "patients", "symptoms", "moderate", "DONEPAZE", "Donepazil", "processes", "breakdown", "attention", "tolerance", "Alzheimer", "Donepezil", "4-6 weeks", "same time", "caregivers", "full glass", "convenience", "Consistency", "information", "bloodstream", "availability", "sterispharma", "independence", "Introduction", "sterisonline", "exact dosage", "starting dose", "acetylcholine", "CALL/WHATSAPP", "Key Ingredient", "Symptom Relief", "overall quality", "daily functions", "optimal results", "neurotransmitter", "Enhanced Quality", "daily activities", "Slow Progression", "clinical response", "patient compliance", "Memory Improvement", "Symptom Management", "cognitive abilities", "symptom progression", "healthcare provider", "significant benefits", "Cognitive Enhancement", "learning capabilities", "Administration Dosage", "problem-solving skills", "cholinesterase inhibitor", "Improved Cognitive Function", "consistent medication levels", "consistent therapeutic effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1822, "imageuri": "https://productimages.withfloats.com/actual/66697dec5e294343790be457.png", "tileimageuri": "https://productimages.withfloats.com/tile/66697dec5e294343790be457.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T10:52:25.868Z", "updatedon": "2024-06-27T05:48:12.912Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/donepaze-5-/1822", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DONEPAZE 5 ", "category": "NEUROLOGY RANGE", "tags": [ "donepezil 5 mg uses", "donepezil side effects", "donepezil 5 mg benefits in hindi", "donepezil 5 मिलीग्राम", "donepezil mechanism of action" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66697d19ca84cd189c25b26a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DONEPAZE 10 ", "description": "DONEPAZE 10 \nDonepazil (10mg)\nIntroduction\nDONEPAZE 10 contains Donepezil (10 mg), a cholinesterase inhibitor used to treat the symptoms of Alzheimer’s disease. Donepezil works by increasing the levels of acetylcholine, a neurotransmitter associated with memory and learning, in the brain. This medication is designed to improve cognitive function, enhance memory, and slow the progression of symptoms in patients with Alzheimer's disease.\n\nKey Ingredient and Its Benefits\nDonepezil (10 mg)\nCognitive Enhancement: Donepezil improves cognitive function in patients with Alzheimer’s disease by increasing the availability of acetylcholine in the brain.\nMemory Improvement: It helps enhance memory and learning capabilities by slowing the breakdown of acetylcholine, a neurotransmitter essential for these processes.\nSymptom Management: Donepezil is effective in managing the symptoms of mild to moderate Alzheimer’s disease, helping patients maintain their daily functions and quality of life.\nSlow Progression: While not a cure, Donepezil can slow the progression of Alzheimer's symptoms, providing significant benefits to patients and caregivers.\nBenefits of DONEPAZE 10\nImproved Cognitive Function: DONEPAZE 10 enhances cognitive abilities, including memory, attention, and problem-solving skills, in patients with Alzheimer’s disease.\nSymptom Relief: It effectively manages the symptoms of Alzheimer’s disease, helping patients maintain their independence and perform daily activities.\nEnhanced Quality of Life: By improving cognitive function and slowing symptom progression, DONEPAZE 10 enhances the overall quality of life for patients and provides relief for caregivers.\nOnce-Daily Dosing: The convenience of once-daily dosing improves patient compliance and ensures consistent therapeutic effects.\nDosage and Administration\nDosage\nAlzheimer’s Disease: The recommended starting dose is 5 mg once daily, which may be increased to 10 mg once daily after 4-6 weeks based on clinical response and tolerance. The exact dosage should be determined by a healthcare provider.\nAdministration\nOral Use: Swallow the tablet whole with a full glass of water. It can be taken with or without food.\nConsistency: For optimal results, take DONEPAZE 10 at the same time each day to maintain consistent medication levels in your bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/donepaze-10-133555", "price": 163.0, "discountamount": 48.9, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "mild", "life", "cure", "food", "Order", "EMAIL", "water", "brain", "tablet", "Dosing", "disease", "Oral Use", "symptoms", "DONEPAZE", "patients", "breakdown", "4-6 weeks", "attention", "tolerance", "Donepezil", "same time", "Donepazil", "processes", "Alzheimer", "full glass", "caregivers", "convenience", "Consistency", "bloodstream", "information", "independence", "sterispharma", "availability", "Introduction", "sterisonline", "exact dosage", "starting dose", "CALL/WHATSAPP", "acetylcholine", "Key Ingredient", "Symptom Relief", "overall quality", "optimal results", "daily functions", "neurotransmitter", "Slow Progression", "Enhanced Quality", "daily activities", "clinical response", "Symptom Management", "Memory Improvement", "patient compliance", "healthcare provider", "symptom progression", "cognitive abilities", "significant benefits", "Administration Dosage", "learning capabilities", "Cognitive Enhancement", "problem-solving skills", "cholinesterase inhibitor", "Improved Cognitive Function", "consistent medication levels", "consistent therapeutic effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1821, "imageuri": "https://productimages.withfloats.com/actual/66697d1c844f26002466c8c8.png", "tileimageuri": "https://productimages.withfloats.com/tile/66697d1c844f26002466c8c8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T10:48:57.672Z", "updatedon": "2024-06-27T05:46:34.915Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/donepaze-10-/1821", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DONEPAZE 10 ", "category": "NEUROLOGY RANGE", "tags": [ "donepezil 10 mg price", "donepezil tablets ip 5 mg", "donepezil 10 mg uses", "donepezil side effects", "donepezil 10 mg benefits" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }